Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Presbyopia Correction Using the VIS Optimal Keratoplasty (Opti-K™) System (Phase IIIa)

NCT06487897 is registered in ClinicalTrials.gov with VIS, Inc. as lead sponsor.

NCT NCT06487897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06487897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Presbyopia Correction Using the VIS Optimal Keratoplasty (Opti-K™) System (Phase IIIa)
Lead sponsor
VIS, Inc.
Phase
Phase 3
Overall status
Recruiting
Start date
September 30, 2024
Completion date
December 31, 2027
Enrollment
75 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

presbyopia